| Myocardial reperfusion injury DM Yellon, DJ Hausenloy New England Journal of Medicine 357 (11), 1121-1135, 2007 | 4898 | 2007 |
| Myocardial ischemia-reperfusion injury: a neglected therapeutic target DJ Hausenloy, DM Yellon The Journal of clinical investigation 123 (1), 92-100, 2013 | 2552 | 2013 |
| Preconditioning the myocardium: from cellular physiology to clinical cardiology DM Yellon, JM Downey Physiological reviews 83 (4), 1113-1151, 2003 | 1519 | 2003 |
| Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. MS Marber, DS Latchman, JM Walker, DM Yellon Circulation 88 (3), 1264-1272, 1993 | 1487 | 1993 |
| New directions for protecting the heart against ischaemia–reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway DJ Hausenloy, DM Yellon Cardiovascular research 61 (3), 448-460, 2004 | 1400 | 2004 |
| The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion MJA Walker, MJ Curtis, DJ Hearse, RWF Campbell, MJ Janse, DM Yellon, ... Cardiovascular research 22 (7), 447-455, 1988 | 1384 | 1988 |
| Postconditioning: a form of “modified reperfusion” protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway A Tsang, DJ Hausenloy, MM Mocanu, DM Yellon Circulation research 95 (3), 230-232, 2004 | 1159 | 2004 |
| Anthracycline chemotherapy and cardiotoxicity JV McGowan, R Chung, A Maulik, I Piotrowska, JM Walker, DM Yellon Cardiovascular drugs and therapy 31, 63-75, 2017 | 1127 | 2017 |
| Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury SB Ong, S Subrayan, SY Lim, DM Yellon, SM Davidson, DJ Hausenloy Circulation 121 (18), 2012-2022, 2010 | 1115 | 2010 |
| Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. MS Marber, R Mestril, SH Chi, MR Sayen, DM Yellon, WH Dillmann The Journal of clinical investigation 95 (4), 1446-1456, 1995 | 1101 | 1995 |
| Preconditioning the human myocardium DM Yellon, AM Alkhulaifi, WB Pugsley The Lancet 342 (8866), 276-277, 1993 | 1057 | 1993 |
| Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial DJ Hausenloy, PK Mwamure, V Venugopal, J Harris, M Barnard, ... The Lancet 370 (9587), 575-579, 2007 | 929 | 2007 |
| Cardiovascular remodelling in coronary artery disease and heart failure G Heusch, P Libby, B Gersh, D Yellon, M Böhm, G Lopaschuk, L Opie The Lancet 383 (9932), 1933-1943, 2014 | 890 | 2014 |
| Remote ischemic preconditioning and outcomes of cardiac surgery DJ Hausenloy, L Candilio, R Evans, C Ariti, DP Jenkins, S Kolvekar, ... New England Journal of Medicine 373 (15), 1408-1417, 2015 | 848 | 2015 |
| Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury AK Bose, MM Mocanu, RD Carr, CL Brand, DM Yellon Diabetes 54 (1), 146-151, 2005 | 848 | 2005 |
| Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? DJ Hausenloy, HL Maddock, GF Baxter, DM Yellon Cardiovascular research 55 (3), 534-543, 2002 | 802 | 2002 |
| De novo cardiomyocytes from within the activated adult heart after injury N Smart, S Bollini, KN Dubé, JM Vieira, B Zhou, S Davidson, D Yellon, ... Nature 474 (7353), 640-644, 2011 | 788 | 2011 |
| Remote ischemic conditioning G Heusch, HE Bøtker, K Przyklenk, A Redington, D Yellon Journal of the American College of Cardiology 65 (2), 177-195, 2015 | 749 | 2015 |
| Remote ischaemic preconditioning: underlying mechanisms and clinical application DJ Hausenloy, DM Yellon Cardiovascular research 79 (3), 377-386, 2008 | 745 | 2008 |
| Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection DJ Hausenloy, DM Yellon Heart failure reviews 12, 217-234, 2007 | 733 | 2007 |
